New Research From Mass General Brigham Guides Treatment Regimen for Aggressive Blood Cancer
May 02, 2025
May 02, 2025
BOSTON, Massachusetts, May 2 -- Mass General Brigham issued the following news release:
* * *
New Research from Mass General Brigham Guides Treatment Regimen for Aggressive Blood Cancer
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas.
Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontli . . .
* * *
New Research from Mass General Brigham Guides Treatment Regimen for Aggressive Blood Cancer
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas.
Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontli . . .
